LTRN

Lantern Pharma Inc. - Common Stock (LTRN)

About Lantern Pharma Inc. - Common Stock (LTRN)

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.

Details

Daily high

$1.62

Daily low

$1.47

Price at open

$1.59

52 Week High

$4.70

52 Week Low

$1.11

Market cap

19.8M

Dividend yield

Volume

3,655

Avg. volume

170,556

P/E ratio

-.96

Lantern Pharma Inc. - Common Stock News